Fundamental Analysis
19 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -336.5% | -454.5% | 0 / 3 | -30.0% | -30.47 pp | -31.88 pp | -10.3% | 0.00 | — | 81,2 | −30,0% | −20,0 | −336,5% | — | 24.34 | — |
| Pts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 8.000 (close price on 2026-08-24)EPS (TTM): −634,2
Financial charts
1.Revenue & growth
VND bn81,2Q2/26
1.Revenue & growth
VND bn81,2Q2/26
2.Profit & growth
VND bn-20,0Q2/26
3.Profit mix (Penman)
VND bn-38,1Q2/26
4.Margins & cost structure
%-2.8%Q2/26
5.Returns & cash cycle
% · days-12.8%Q2/26
6.Earnings quality & cash
VND bn21,6Q2/26
7.Asset structure
VND bn450Q2/26
8.Funding & debt health
VND bn · times450Q2/26
9.Revenue backlog
VND bn4,38Q2/26
10.Valuation
times · %-12,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-333Q2/26
Adjusted EPS growth, latest quarter
-337%
Average adjusted EPS growth, 3 quarters
-454%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26